The effects of antipsychotics on weight gain, weight-related hormones and homocysteine in children and adolescents: a 1-year follow-up study

Present and future of developmental neuropsychopharmacology

(2015) Celso Arango   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Concentración sérica de leptina en población escolar de cinco departamentos del centro-oriente colombiano y su relación con parámetros antropométricos y perfil lipídico

(2014) Elpidia Poveda et al.   Biomedica

Effects of second-generation antipsychotics on selected markers of one-carbon metabolism and metabolic syndrome components in first-episode schizophrenia patients

(2014) Błażej Misiak et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Increases in Thyrotropin Within the Near-Normal Range Are Associated With Increased Triiodothyronine But Not Increased Thyroxine in the Pediatric Age Group

(2014) Gilad Karavani et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Antipsychotic Use in Children and Adolescents

(2014) Inmaculada Baeza et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Leptin and cardiometabolic risk factors in obese children and adolescents

(2014) Nathalia C Gonzaga et al.   JOURNAL OF PAEDIATRICS AND CHILD HEALTH

Second-Generation Antipsychotic Use in Children and Adolescents: A Six-Month Prospective Cohort Study in Drug-Naïve Patients

(2014) Celso Arango et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

The relation of leptin and soluble leptin receptor levels with metabolic and clinical parameters in obese and healthy children

(2014) Gonul Catli et al.   PEPTIDES

High Plasma Homocysteine Increases Risk of Metabolic Syndrome in 6 to 8 Year Old Children in Rural Nepal

(2014) Mohsin Yakub et al.   Nutrients

Weight gain and increase of body mass index among children and adolescents treated with antipsychotics: a critical review

(2013) José María Martínez-Ortega et al.   EUROPEAN CHILD & ADOLESCENT PSYCHIATRY

The effects of second-generation antipsychotics on food intake, resting energy expenditure and physical activity

(2013) C Cuerda et al.   EUROPEAN JOURNAL OF CLINICAL NUTRITION

Thyroid-stimulating hormone (TSH) level in nutritionally obese children and metabolic co-morbidity

(2013) Cenk Aypak et al.   JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM

National Trends in the Office-Based Treatment of Children, Adolescents, and Adults With Antipsychotics

(2012) Mark Olfson et al.   ARCHIVES OF GENERAL PSYCHIATRY

Body composition and metabolic parameters are associated with variation in thyroid hormone levels among euthyroid young men

(2012) Greet Roef et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Cardiovascular disease risk in healthy children and its association with body mass index: systematic review and meta-analysis

(2012) C. Friedemann et al.   BMJ-British Medical Journal

Efectos secundarios del tratamiento antipsicótico en niños y adolescentes naïve o quasi-naïve: diseño de un protocolo de seguimiento y resultados basales

(2012) Jessica Merchán-Naranjo et al.   Revista de Psiquiatria y Salud Mental

Thyroid function in the nutritionally obese child and adolescent

(2011) Thomas Reinehr   CURRENT OPINION IN PEDIATRICS

Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: Comprehensive review of prospective head-to-head and placebo-controlled comparisons

(2010) David Fraguas et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Thyroid Function in Obese Children and Adolescents

(2010) Valeria Marras et al.   Hormone Research in Paediatrics

Risperidone associated weight, leptin, and anthropometric changes in children and adolescents with psychotic disorders in early treatment

(2010) Lawrence A. Maayan et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Plasma orexin A, ghrelin, cholecystokinin, visfatin, leptin and agouti-related protein levels during 6-week olanzapine treatment in first-episode male patients with psychosis

(2010) Cengiz Basoglu et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Antipsychotic Dose Equivalents and Dose-Years: A Standardized Method for Comparing Exposure to Different Drugs

(2009) Nancy C. Andreasen et al.   BIOLOGICAL PSYCHIATRY

Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents

(2009) Christoph U. Correll   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Weight Gain and Metabolic Abnormalities During Extended Risperidone Treatment in Children and Adolescents

(2009) Chadi A. Calarge et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Lack of Effect of Stimulant Combination with Second-Generation Antipsychotics on Weight Gain, Metabolic Changes, Prolactin Levels, and Sedation in Youth with Clinically Relevant Aggression or Oppositionality

(2009) Julie B. Penzner et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Effect of Antipsychotics on Peptides Involved in Energy Balance in Drug-Naive Psychotic Patients After 1 Year of Treatment

(2009) Rocio Perez-Iglesias et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Obesity and thyroid function

(2009) Thomas Reinehr   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Contributing factors to weight gain during long-term treatment with second-generation antipsychotics. A systematic appraisal and clinical implications

(2009) S. Gentile   Obesity Reviews

The role of histaminergic H1 and H3 receptors in food intake: A mechanism for atypical antipsychotic-induced weight gain?

(2009) Chao Deng et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Metabolic and Cardiovascular Adverse Events Associated With Antipsychotic Treatment in Children and Adolescents

(2008) Roger S. McIntyre et al.   ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE

Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin

(2008) Hua Jin et al.   SCHIZOPHRENIA RESEARCH

Leptin and Ghrelin Levels in Patients With Schizophrenia During Different Antipsychotics Treatment: A Review

(2007) O. Sentissi et al.   SCHIZOPHRENIA BULLETIN